FDA Seeking Input On Long-Term Follow-Up For HIV Entry Inhibitors

FDA and the Forum for Collaborative HIV Research will hold a public meeting on Jan. 18 to discuss the appropriate collection of long-term follow-up data for CCR5 antagonist clinical trials.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet